Roche Strengthens Its Bet Against the “Superbug”By Ion Jauregui – Analyst at ActivTrades
Zosurabalpin: A New Hope Against Antimicrobial Resistance
Swiss pharmaceutical giant Roche (SWX: ROG) has just taken a major step forward in the fight against bacterial resistance: its new antibiotic zosurabalpin is entering Phase 3 clinical trials. The co
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
11.8 CHF
8.28 B CHF
60.49 B CHF
29.01 M
About Roche Holding Ltd
Sector
Industry
CEO
Thomas Schinecker
Website
Headquarters
Basel
Founded
1896
ISIN
CH0012032113
FIGI
BBG000BCLWW1
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
Related stocks
Roche vs. Novo Nordisk: Who will suffer the Weight Loss?Roche (ticker: ROG.SW) is losing ground on the stock due to the side effects of its new weight loss pill, CT-996, which is still in the testing phase. After a rally that boosted its shares 40% between May and September, the Swiss drugmaker has seen an 11% drop in its shares in September alone, inclu
Roche Analysis 6/26DISCLOSURE: as of 6/26 I have no open position in SIX:RO
Roche is a Swiss based pharmaceutical conglomerate with a diverse range of operations and brands. The company has a long history of profitability and high returns on investment.
Management Effectiveness: Roche has been around since 1896
Roche: Ready for 120% Growth?We're trying something with Roche here, where we think that we are currently in Wave (5), having recently completed Wave (4). This assessment is better visualized on the daily chart. Hence, we should maintain the 61.8% level for this Wave 4. Anything below would statistically be too low, while above
Hold it like a rock - Roche, what an opportunity.Hi, 1PERCENT here.
Roche Holding, a Swiss multinational biopharma company. It is like the Apple of biopharma.
There were only 3 pull backs greater than 30% in the history of the stock.
2002 ~ 2003: -45.33%
2006 ~ 2011: -52.40%
2014 ~ 2018: -30.24%
2022 ~ present: -44.89%
It is at the support z
Roche HoldingsThis is one of those companies you can't afford not to look into. Roche is one of the world's largest biotech companies and a global leader in pharmaceuticals and diagnostics. This leading position translates to strong market share, revenue, and profitability. The company operates across various seg
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
A3K88A
Roche Kapitalmarkt AG 2.0% 23-SEP-2032 2022-23.09.32 GUARANTEEDYield to maturity
—
Maturity date
Sep 23, 2032
CHGCY5698748
Roche Holdings, Inc. 5.593% 13-NOV-2033Yield to maturity
—
Maturity date
Nov 13, 2033
CHGCY4184535
Roche Holdings, Inc. 4.0% 28-NOV-2044Yield to maturity
—
Maturity date
Nov 28, 2044
A3LRKK
Roche Kapitalmarkt AG 1.75% 15-SEP-2033 2023-15.09.33Yield to maturity
—
Maturity date
Sep 15, 2033
CHGCY5766482
Roche Holdings, Inc. 4.909% 08-MAR-2031Yield to maturity
—
Maturity date
Mar 8, 2031
CHGCY4307677
Roche Holdings, Inc. 3.0% 10-NOV-2025Yield to maturity
—
Maturity date
Nov 10, 2025
A3K2NX
Roche Kapitalmarkt AG 1.0% 25-FEB-2037 2022-25.02.37 GUARANTEED REG SYield to maturity
—
Maturity date
Feb 25, 2037
CHGCY5317644
Roche Holdings, Inc. 2.607% 13-DEC-2051Yield to maturity
—
Maturity date
Dec 13, 2051
CHGCY5766485
Roche Holdings, Inc. 5.218% 08-MAR-2054Yield to maturity
—
Maturity date
Mar 8, 2054
A3LQ44
Roche Kapitalmarkt AG 1.6% 15-SEP-2028 2023-15.09.28Yield to maturity
—
Maturity date
Sep 15, 2028
CHGCY4391962
Roche Holdings, Inc. 7.0% 01-MAR-2039Yield to maturity
—
Maturity date
Mar 1, 2039
See all RO bonds
Curated watchlists where RO is featured.
Frequently Asked Questions
The current price of RO is 289.2 CHF — it has decreased by −1.09% in the past 24 hours. Watch Roche Holding Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange Roche Holding Ltd stocks are traded under the ticker RO.
RO stock has risen by 4.86% compared to the previous week, the month change is a 9.13% rise, over the last year Roche Holding Ltd has showed a −3.79% decrease.
We've gathered analysts' opinions on Roche Holding Ltd future price: according to them, RO price has a max estimate of 438.00 CHF and a min estimate of 230.00 CHF. Watch RO chart and read a more detailed Roche Holding Ltd stock forecast: see what analysts think of Roche Holding Ltd and suggest that you do with its stocks.
RO stock is 1.73% volatile and has beta coefficient of 1.30. Track Roche Holding Ltd stock price on the chart and check out the list of the most volatile stocks — is Roche Holding Ltd there?
Today Roche Holding Ltd has the market capitalization of 230.30 B, it has increased by 0.25% over the last week.
Yes, you can track Roche Holding Ltd financials in yearly and quarterly reports right on TradingView.
Roche Holding Ltd is going to release the next earnings report on Jan 29, 2026. Keep track of upcoming events with our Earnings Calendar.
RO earnings for the last half-year are 11.08 CHF per share, whereas the estimation was 10.46 CHF, resulting in a 5.98% surprise. The estimated earnings for the next half-year are 8.57 CHF per share. See more details about Roche Holding Ltd earnings.
Roche Holding Ltd revenue for the last half-year amounts to 31.85 B CHF, despite the estimated figure of 30.88 B CHF. In the next half-year revenue is expected to reach 31.46 B CHF.
RO net income for the last half-year is 7.41 B CHF, while the previous report showed 2.02 B CHF of net income which accounts for 267.01% change. Track more Roche Holding Ltd financial stats to get the full picture.
Yes, RO dividends are paid annually. The last dividend per share was 9.70 CHF. As of today, Dividend Yield (TTM)% is 3.35%. Tracking Roche Holding Ltd dividends might help you take more informed decisions.
Roche Holding Ltd dividend yield was 3.58% in 2024, and payout ratio reached 93.40%. The year before the numbers were 3.67% and 66.71% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 7, 2025, the company has 103.25 K employees. See our rating of the largest employees — is Roche Holding Ltd on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Roche Holding Ltd EBITDA is 21.98 B CHF, and current EBITDA margin is 35.81%. See more stats in Roche Holding Ltd financial statements.
Like other stocks, RO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Roche Holding Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Roche Holding Ltd technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Roche Holding Ltd stock shows the buy signal. See more of Roche Holding Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.